Skip to main content

Lisinopril and Hydrochlorothiazide

NDC 51655-413 · Northwind Health Company, LLC

Generic nameLisinopril and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)HYDROCHLOROTHIAZIDE, LISINOPRIL
Strength25; 20 mg/1; mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

51655-413-26 — 90 TABLET in 1 BOTTLE, PLASTIC (51655-413-26)

51655-413-30 — 30 TABLET in 1 BOTTLE, DISPENSING (51655-413-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51655-146 — Lisinopril, 51655-232 — Lisinopril, 51655-243 — valsartan and hydrochlorothiazide, 51655-272 — hydrochlorothiazide, 51655-311 — Lisinopril and Hydrochlorothiazide, 51655-335 — Lisinopril, 51655-389 — valsartan and hydrochlorothiazide, 51655-399 — Lisinopril, 51655-411 — Lisinopril, 51655-412 — Lisinopril and Hydrochlorothiazide, 51655-414 — Lisinopril and Hydrochlorothiazide, 51655-422 — Hydrochlorothiazide, 51655-486 — Lisinopril, 51655-502 — Hydrochlorothiazide, 51655-506 — Hydrochlorothiazide, 51655-515 — Hydrochlorothiazide, 51655-522 — hydrochlorothiazide, 51655-582 — Triamterene and Hydrochlorothiazide, 51655-616 — Hydrochlorothiazide, 51655-630 — Triamterene and Hydrochlorothiazide, +1122 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels